{"id":1749,"date":"2020-03-04T17:02:56","date_gmt":"2020-03-04T22:02:56","guid":{"rendered":"https:\/\/www.bumc.bu.edu\/rheumatology\/?p=1749"},"modified":"2020-03-04T17:02:56","modified_gmt":"2020-03-04T22:02:56","slug":"in-the-news-tuhina-neogi-in-endocrineweb","status":"publish","type":"post","link":"https:\/\/www.bumc.bu.edu\/rheumatology\/2020\/03\/04\/in-the-news-tuhina-neogi-in-endocrineweb\/","title":{"rendered":"In the News: Tuhina Neogi in endocrineweb"},"content":{"rendered":"<h1 class=\"title\"><img loading=\"lazy\" src=\"https:\/\/static.endocrineweb.com\/sites\/all\/themes\/endo\/logopro.png\" alt=\"EndocrineWeb\" width=\"270\" height=\"65\" \/><\/h1>\n<div id=\"content-header\">\n<h1 class=\"title\">Gout Management\u2014Need for Greater Attentiveness to Broader Treatment<\/h1>\n<h3 class=\"subtitle\">Treating patients at risk for or diagnosed with type 2 diabetes should be closely monitored for gout-related disease, with treat-to-target therapy initiated early with ongoing monitoring, informed by new consensus statement, and clinical guidelines pending from the American College of Rheumatology.<\/h3>\n<\/div>\n<div id=\"content-area\">\n<div id=\"node-62593\" class=\"node clearfix node-type-pro_article\">\n<div class=\"node-inner\">\n<div class=\"article-authored-by\">Written by <a href=\"https:\/\/www.endocrineweb.com\/author\/15752\/doheny\" rel=\"author\">Kathleen Doheny<\/a><\/div>\n<div class=\"content\">\n<p><em>with John FitzGerald, MD, Tuhina Neogi, MD, PhD, and David Bursill, MD<\/em><\/p>\n<p>Read the full <a href=\"https:\/\/www.endocrineweb.com\/professional\/metabolic-syndrome\/gout-considerations-need-changing-broader-treatment-implemented\">article<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Gout Management\u2014Need for Greater Attentiveness to Broader Treatment Treating patients at risk for or diagnosed with type 2 diabetes should be closely monitored for gout-related disease, with treat-to-target therapy initiated early with ongoing monitoring, informed by new consensus statement, and clinical guidelines pending from the American College of Rheumatology. Written by Kathleen Doheny with John [&hellip;]<\/p>\n","protected":false},"author":4477,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.bumc.bu.edu\/rheumatology\/wp-json\/wp\/v2\/posts\/1749"}],"collection":[{"href":"https:\/\/www.bumc.bu.edu\/rheumatology\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bumc.bu.edu\/rheumatology\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/rheumatology\/wp-json\/wp\/v2\/users\/4477"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/rheumatology\/wp-json\/wp\/v2\/comments?post=1749"}],"version-history":[{"count":1,"href":"https:\/\/www.bumc.bu.edu\/rheumatology\/wp-json\/wp\/v2\/posts\/1749\/revisions"}],"predecessor-version":[{"id":1750,"href":"https:\/\/www.bumc.bu.edu\/rheumatology\/wp-json\/wp\/v2\/posts\/1749\/revisions\/1750"}],"wp:attachment":[{"href":"https:\/\/www.bumc.bu.edu\/rheumatology\/wp-json\/wp\/v2\/media?parent=1749"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/rheumatology\/wp-json\/wp\/v2\/categories?post=1749"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/rheumatology\/wp-json\/wp\/v2\/tags?post=1749"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}